Home › Leukemia › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Leukemia sa Philadelphia, PA

Isang pag-aaral para sa Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Nagre-recruitPhase 1/2

University of Pennsylvania, Philadelphia

30 Days · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04065399

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Nagre-recruitPhase 1

Children's Hospital of Philadelphia, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07586618

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3

University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia

Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

Nagre-recruitObservasyonal na pag-aaral

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Edad 60 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT03680677

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 29 · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07464951

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral

Saint Christopher's Hospital for Children, Philadelphia

Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia, Philadelphia

1 Month – 25 Years · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06839456

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1

Hospital of the University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

Nagre-recruitMaagang Phase 1

Children's Hospital of Philadelphia, Philadelphia

Hanggang edad 30 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT02356653

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Philadelphia

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Leukemia sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.